MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2019 International Congress

    Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

    F. Naz, R. X, YHS. Siddique (Aligarh, India)

    Objective: To evaluate the behavioural changes in transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by different doses of Ropinirole alginate nanocomposite (RANC).…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Predicting Impulse Control Disorders in Parkinson’s Disease: A Challenging Task

    J. Faouzi, S. Bekadar, O. Colliot, JC. Corvol (Paris, France)

    Objective: To predict the onset of impulse control disorders (ICDs) in Parkinson’s disease (PD) in several scenarios of interest for clinicians. Background: Impulse control disorders…
  • 2019 International Congress

    Subchronic copper exposure induces parkinsonism in rats: Neuromodulatory potential of curcumin

    A. Abbaoui, H. Gamrani (Marrakech, Morocco)

    Objective: We aim herein to assess the effect of subchronic Cu-intoxication (0.125%) for 6 weeks on the dopaminergic, serotonergic and astroglial systems together with behavioral…
  • 2019 International Congress

    Prospective study on impulsive-compulsive behaviours in early Parkinson’s disease

    V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess longitudinally impulsive-compulsive behaviours (ICBs) in a cohort of Parkinson's disease (PD) patients at the initial stage of the disease during 5 years…
  • 2019 International Congress

    Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

    J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

    Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…
  • 2019 International Congress

    Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

    F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)

    Objective: To evaluate the relationship between the presence of dyskinesia objectively detected using a wearable device and the presence of active and past impulsive compulsive…
  • 2019 International Congress

    Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

    J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To longitudinally evaluate the role of depression in the development of impulse control disorders (ICD) in Parkinson's disease (PD) patients. Background: Depression has been…
  • 2019 International Congress

    Diagnosis and management strategies used in series of Parkinson’s disease patients who experienced subthalamic nucleus deep brain stimulation induced mood elevation

    L. Spiegel, J. Weinstein, J. Ostrem, A. Seritan (San Francisco, CA, USA)

    Objective: To describe the diagnosis and management of deep brain stimulation-induced elevated mood states. Background: Deep brain stimulation (DBS) is an FDA-approved surgical treatment option…
  • 2019 International Congress

    The Urge to Move in Restless Legs Syndrome Associated with Parkinson’s Disease: A Motor Impulse Control Disorder?

    A. Marques, C. Lambert, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

    Objective: To determine whether there could be a semiological overlap between Restless Legs Syndrome (RLS) and Impulse Control Disorders (ICDs) in Parkinson’s Disease (PD), using…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley